About the Conference
This joint conference of the Food and Drug Administration and the Center for Contemporary History and Policy at the Chemical Heritage Foundation will examine the past 100 years of the FDA and facilitate discussion of current and near-term issues in risk and regulation. The conference will promote dialogue among regulators and constituent communities, including industry and public interest groups. Outcomes will include educating participants about issues in regulation and identifying models for the future.
Each panel will feature two 25-minute presentations, one by an FDA representative and one by an industry representative. Speakers will address how to regulate during a period of rapid change in science and technology, the relationship of regulation to competitiveness in a globalizing economy, and the role of business and government in light of changes in how consumers obtain and use health information.
Welcome and Introductions
9:00-9:30AM
Susan Setterberg, FDA Regional Director
Arthur Daemmrich, Director, Center for Contemporary History and Policy,
CHF
Suzanne White Junod, FDA Historian
Opening Plenary: Turning Points in FDA History
9:30-10AM
Peter Barton Hutt, Senior Counsel, Covington and Burling
Panel 1: Drug Regulation
10-10:30AM
Steven Galson, Director, FDA Center for Drug Evaluation and Research
10:30-11AM
Ronald Krall, Senior Vice President, Worldwide Development,
GlaxoSmithKline
Panel 2: Medic
'"/>
Contact: Neil Gussman
neilg@chemheritage.org
215-873-8262
Chemical Heritage Foundation
8-Feb-2006